News
14h
SurvivorNet on MSNA New Treatment Combination Shows Promise For Hard-To-Treat Triple-Negative Breast Cancer — What New Data Means For PatientsThe drug Trodelvy (drug name sacituzumab govitecan-hziy) is showing promise for first-line metastatic triple-negative breast ...
16hon MSN
In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus ...
Kura Oncology and Kyowa Kirin have shared details of the phase 2 win for their oral leukemia treatment ziftomenib as the FDA ...
Information from the patient's medical record, laboratory test results, clinical response, and the medication profile should be considered in monitoring a patient's response to medications.
Meditation could be prescribed in lieu of medication for patients who experience severe ... treatment regimens based on their patient profiles. And she hopes that the research leads to more ...
Anti-OX40 medications have been associated with positive efficacy and safety outcomes for the treatment of atopic dermatitis.
it is still unlikely that he would miss all of the refills of every medication in his medication profile. Furthermore, it can be assumed that the majority of the Vietnamese patients were required ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results